NephroDI Therapeutics is a pharmaceutical company focusing on concentration disorders of the kidney, specifically developing an oral drug to treat Nephrogenic Diabetes Insipidus (NDI) in children, a pediatric orphan disease
NephroDI Therapeutics is a pharmaceutical company focusing on concentration disorders of the kidney, specifically developing an oral drug to treat Nephrogenic Diabetes Insipidus (NDI) in children, a pediatric orphan disease.